Loading...
Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors with Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033
IMPORTANCE: Initial results of this intergroup trial of imatinib for patients with metastatic/ unresectable GIST were reported in 2008 (http://www.ncbi.nlm.nih.gov/pubmed/18235122). Updated results reported here show long-term survival with a significant subset of patients surviving 10 or more years...
Na minha lista:
| Udgivet i: | JAMA Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5727908/ https://ncbi.nlm.nih.gov/pubmed/28196207 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2016.6728 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|